![The association of clinical splenomegaly, axillary, and inguinal lymphadenopathies with high blood lactate dehydrogenase level and leukocytosis suggested mature lymphoproliferation. An ^18^F-FDG PET/CT scan was performed. **A**, FDG PET MIP image. **B**, PET/CT fusion. **C**, Postcontrast chest CT axial slices. Thoracic and subdiaphragmatic lymph node involvement with high FDG uptake (SUV~max~, 8.7; arrows). Note a major mesenteric infiltration (arrowheads). Inguinal lymph node biopsy specimen confirmed mantle cell lymphoma with high proliferative index (Ki67 = 70%).](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003113-g001){#FU1}

![FDG PET/CT (**A**) and chest CT (**B**) axial slices: bilateral ground glass opacities (arrows) and curvilinear opacities (arrowheads), with predominance in the posterior subpleural areas, suggesting installation of COVID-19--associated pneumopathy. These findings were associated with a moderate FDG uptake (SUV~max~, 4). This case illustrates the typical chest CT findings in COVID-19 recently described: possible negativity within the first 3 days of clinical onset in 50% of cases^[@bib1]^; multiple bilateral ground glass opacities, curvilinear subpleural opacities, and predominance in middle and lower lobes and posterior areas, septal thickening, and crazy paving pattern^[@bib2]--[@bib4]^; and progressive transformation into multifocal consolidative opacities, with greatest severity about 10 days after the clinical onset.^[@bib5]^ A study including 1014 cases in Wuhan (China) demonstrated the high sensitivity (97%) of chest CT for diagnosis of COVID-19.^[@bib6]^ Radiologic evaluation of disease extent has also a probable prognostic implication.^[@bib7]^ A lobar alveolar consolidation with adenomegalies should raise the diagnosis of bacterial coinfection. This case highlights the PET/CT features of COVID-19, in accordance with recent publications^[@bib8],[@bib9]^: FDG moderate to intense uptake, as commonly seen in pulmonary infections. Considering the heterogeneous clinical setup of the disease, the rapid increase in the number of cases worldwide, the rate of false-negative of RT-PCR (approximately 33%),^[@bib6]^ and, finally, our patients' profile with severe comorbidities and potential immunosuppressive therapies, nuclear medicine specialists should carefully describe and report these patterns.](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003113-g002){#FU2}
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